Thus, CYR61 may be one of the driving molecules for enhancing EMT-related pathways (Wnt and PI3K/AKT signals) [9], [40] in early-onset CRC patients via the CYR61-FAK axis (Figure 3). Here, AKT1 is linked to colorectal carcinoma.